Efficacy and safety of dostarlimab in elderly patients with multiple comorbidities and allergic diathesis: case report
The administration of dostarlimab is safe and feasible in elderly people with multiple pathologies and multiple allergies with recurrent dMMR/MSI EC. The drug is well tolerated and able to give a good quality of life to patients.
Authors
- Antonino Vallone
- Roberto Bordonaro (ORCID: https://orcid.org/0000-0001-5005-0880)
- Katia Lanzafame (ORCID: https://orcid.org/0000-0001-7358-3946)
- Giuseppe Ettore (ORCID: https://orcid.org/0000-0002-5765-7682)
- Angela Russo (ORCID: https://orcid.org/0000-0003-2116-3258)
- Marco D’Asta
- Giusi Blanco
- Carla Ettore (ORCID: https://orcid.org/0000-0003-0864-2801)
- Maria Rosaria Sapienza (ORCID: https://orcid.org/0000-0002-1078-2128)
- Sabrina Paratore
- Eliana Giurato
- Giulia Bonanno
Institutions
- Ospedale Garibaldi (IT)
- Azienda di Rilievo Nazionale ed Alta Specializzazione (IT)
Publication Details
- Journal
- AME Case Reports
- Published
- 2025-06-22
- DOI
- https://doi.org/10.21037/acr-24-239
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00